Cantab Biopharmaceuticals

Cantab Biopharmaceuticals is a specialist biotechnology company based in Cambridge, UK, focused on the development of biosimilars and the provision of contract development and manufacturing services. The company leverages its expertise in microbial and mammalian expression systems to develop high-quality biopharmaceutical products, including recombinant proteins and monoclonal antibodies. Cantab's portfolio includes biosimilar versions of established biologics such as G-CSF, Interferon-beta, and TNF-alpha inhibitors. In addition to its internal pipeline, the company offers comprehensive CDMO services ranging from cell line development and process optimization to analytical validation and GMP manufacturing. Cantab Biopharmaceuticals operates as a subsidiary of the Fereydoun and Homeira Selahi (FHS) Group, maintaining a strong focus on expanding access to affordable biologic therapies globally.